End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.61 CNY | -0.66% | +1.14% | +8.38% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 15 | China stocks rise after new guidelines; HK shares drop | RE |
Sales 2024 * | 13.35B 1.84B | Sales 2025 * | 14.69B 2.03B | Capitalization | 14.23B 1.96B |
---|---|---|---|---|---|
Net income 2024 * | 863M 119M | Net income 2025 * | 996M 137M | EV / Sales 2024 * | 1.07 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
16.6
x | P/E ratio 2025 * |
14.3
x | Employees | 11,608 |
Yield 2024 * |
14.1% | Yield 2025 * |
17% | Free-Float | 39.64% |
1 day | -0.66% | ||
1 week | +1.14% | ||
Current month | +18.68% | ||
1 month | +20.43% | ||
3 months | +16.34% | ||
6 months | +8.71% | ||
Current year | +8.38% |
Managers | Title | Age | Since |
---|---|---|---|
Wan Yong Lian
PSD | President | 54 | 22-09-23 |
Hao Li
DFI | Director of Finance/CFO | 59 | 16-11-17 |
Qian Yin Jing
IRC | Investor Relations Contact | 44 | 19-09-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yong Gang Xing
CHM | Chairman | 48 | 19-11-24 |
Yong Liu
BRD | Director/Board Member | 55 | 21-05-16 |
Shu Yuan Wei
BRD | Director/Board Member | 60 | 20-05-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 10.61 | -0.66% | 24,159,470 |
24-04-25 | 10.68 | +2.69% | 32,644,090 |
24-04-24 | 10.4 | +0.39% | 26,739,850 |
24-04-23 | 10.36 | -1.52% | 24,845,240 |
24-04-22 | 10.52 | +0.29% | 33,565,740 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.38% | 1.96B | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 600420 Stock